This HTML5 document contains 162 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q31437386
rdf:type
wikibase:Item
schema:description
2000年論文 articolo scientifico vetenskaplig artikel artigo científico (publicado na 2000) научная статья naučni članak vitskapeleg artikkel سائنسی مضمون مقالة علمية: نشرت في يوليو 2000 2000년 논문 2000年论文 2000年論文 2000年の論文 artigo científico bilimsel makale bài báo khoa học wetenschappelijk artikel мақолаи илмӣ vědecký článek 2000 թվականի հուլիսին հրատարակված գիտական հոդված vedecký článok наукова стаття, опублікована в липні 2000 tudományos cikk artykuł naukowy wissenschaftlicher Artikel artikull shkencor artículo científico publicado en 2000 mokslinis straipsnis სამეცნიერო სტატია article scientific 2000年论文 2000年论文 article científic vitenskapelig artikkel teaduslik artikkel tieteellinen artikkeli artículu científicu espublizáu en 2000 ২০০০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالهٔ علمی מאמר מדעי 2000年論文 2000年论文 articol științific 2000年論文 мақолаи илмӣ ശാസ്ത്രപ്രബന്ധം​ scientific article article scientifique (publié 2000) научна статия artikulong pang-agham บทความทางวิทยาศาสตร์ scienca artikolo научни чланак videnskabelig artikel (udgivet 2000) 2000年论文 2000年论文 2000年論文 2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած επιστημονικό άρθρο 2000 nî lūn-bûn artigo científico (publicado na 2000) научни чланак
p:P577
wds:Q31437386-975A3BFE-6F8A-4C9C-BE1E-55B6E5F7E58C
wdt:P577
2000-07-01T00:00:00Z
p:P407
wds:Q31437386-494EC7ED-2D5B-4A18-AAF6-46074E024A15
wdt:P407
wd:Q1860
p:P2860
wds:Q31437386-EA19A9BA-51A4-4E6B-8AFF-6E482D8434FA wds:Q31437386-F0D45D84-CCEA-47CA-BF71-08E59EA536E7 wds:Q31437386-03D8FB76-8531-430A-A2B3-FEF8AA22A5C4 wds:Q31437386-03EA4DA3-73BB-47BB-B444-58DED0E2BA88 wds:Q31437386-0C2FF710-B0A4-44CC-B29B-165F2E30F8E5 wds:Q31437386-165CA974-4EDA-45DB-A4D2-4C76BD428A07 wds:Q31437386-2B097475-F5AC-436A-B576-1211CAFF2525 wds:Q31437386-7340815A-9500-40B6-A52A-44E9FCFA51F9 wds:Q31437386-73FDD86B-463E-4CB5-AB01-6C57EBF3ACAD wds:Q31437386-7567A626-BFF9-41CD-B190-BDBB6FCE2C57 wds:Q31437386-782175DD-8C14-4393-9E1B-47D191DFB33D wds:Q31437386-8050C0E5-52BD-4662-A710-F64A1CBBA3D7 wds:Q31437386-8502207C-74F5-4E9D-915A-972FEEBE3590 wds:Q31437386-03BFF848-B63B-4EE2-8FD2-712D30F95C71 wds:Q31437386-495204DE-7923-450A-AE79-D7227F52AE29 wds:Q31437386-4A88B083-DFE2-4134-9601-839903320D91 wds:Q31437386-5086B708-7343-46FE-80E6-9B644DA089B7 wds:Q31437386-54C1631E-9138-47EC-B203-18166BD464BC wds:Q31437386-6520A722-D7C2-45DB-A302-278922DA55BA wds:Q31437386-6CBAF646-AD7F-4058-9841-0E27AC6B8959 wds:Q31437386-DEA30854-0255-481F-B6B0-F4A232C9EA5A wds:Q31437386-E8FD21C1-9B84-428A-ABB7-07583F6D424B wds:Q31437386-8DAEBA9E-2C52-4150-B7E7-91E3CDE0E9AD wds:Q31437386-AF1A2B28-2D17-4A49-81A5-686A09CBC0AB wds:Q31437386-B163270B-23AA-4CE2-A846-9699E9EBC76B
wdt:P2860
wd:Q71755282 wd:Q29391703 wd:Q32053074 wd:Q50934595 wd:Q77904788 wd:Q45285350 wd:Q71396282 wd:Q33797387 wd:Q53336366 wd:Q51036865 wd:Q51557409 wd:Q73218242 wd:Q29619460 wd:Q34303127 wd:Q93923048 wd:Q42757892 wd:Q73497892 wd:Q78049398 wd:Q33854955 wd:Q34502430 wd:Q29615603 wd:Q78049497 wd:Q40763495 wd:Q50850450 wd:Q71827589
p:P2093
wds:Q31437386-28C437F2-732C-4AC1-B4A4-BFAD6B0781C2 wds:Q31437386-CA8A32DC-DFFE-4E4D-84B9-CA8821F016F9 wds:Q31437386-A895C4F0-240E-4278-BD34-77E9DC0D2BA0 wds:Q31437386-770A5D14-AA4F-468C-A271-563394C4BDFD wds:Q31437386-54163380-9859-4D46-8D3C-B7B3065AF69C wds:Q31437386-51EF70BB-FF53-41FF-9E0E-16D5E6249119
wdt:P2093
C R Palmer T Rosenthal M J Brown A Castaigne L M Ruilope G Mancia
rdfs:label
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
skos:prefLabel
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
schema:name
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
p:P50
wds:Q31437386-E50B2A01-CC54-4121-8CE0-553C19ADC0B3
wdt:P50
wd:Q46001914
p:P1476
wds:Q31437386-E521C426-12E4-427E-9202-92CD1826A07D
wdt:P1476
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
p:P304
wds:Q31437386-DF6C28FB-10BB-44A2-9EAD-1CB4B0EAD7D8
wdt:P304
366-372
p:P31
wds:Q31437386-A5614802-C75E-4283-BBBB-858E9C7D0E81
wdt:P31
wd:Q13442814
p:P921
wds:Q31437386-C0A00B94-ADFE-4646-A273-82A686541F7E wds:Q31437386-D677D23C-BBF6-490E-9118-B43061EE81FB
wdt:P921
wd:Q39111 wd:Q95566669
p:P698
wds:Q31437386-7C4B57F8-3FBF-4547-8BAA-B9B72C4D1BCA
wdtn:P698
n12:10972368
wdt:P698
10972368
p:P1433
wds:Q31437386-202348A5-7498-48EA-BC71-28E8D8C849F1
wdt:P1433
wd:Q939416
p:P433
wds:Q31437386-038CA001-7517-4A20-BD85-D6CA25EDF20D
p:P478
wds:Q31437386-A95EB354-111B-4FB9-A7AE-5135D6AD4B7B
wdt:P433
9227
wdt:P478
356
p:P356
wds:Q31437386-B3238D12-96B0-4426-BF6E-3639A7D936BE
wdtn:P356
n10:S0140-6736(00)02527-7
wdt:P356
10.1016/S0140-6736(00)02527-7